Browsing publications by Dr Desa Lilic

Newcastle AuthorsTitleYearFull text
Dr Katherine Crossland
Dr Chun Chan
Tariq AlShehri
Dr Mario Abinun
Dr Andrew Gennery
et al.
Gain-of-function STAT1 mutations impair STAT3 activity in patients with Chronic Mucocutaneous Candidiasis (CMC)2015
Tariq AlShehri
Dr Desa Lilic
Use of ruxolitinib to successfully treat chronic mucocutaneous candidiasis caused by gain-of-function signal transducer and activator of transciption 1 (STAT1) mutation2015
Dr Katherine Crossland
Dr Mario Abinun
Dr Andrew Gennery
Dr Jelena Mann
Dr Dennis Lendrem
et al.
Gain-of-function stat1 mutation impairs stat3 function predisposing to chronic mucocutaneous candidiasis2014
Dr Mario Abinun
Dr Stephen Hodges
Dr Timothy Cheetham
Dr Milos Ognjanovic
Professor Alastair Burt
et al.
Immunomodulatory Therapy for Severe Autoimmune Polyendocrinopathy Type-1 (APS-1)2014
Dr Katherine Crossland
Professor Simon Pearce
Dr Mario Abinun
Dr Timothy Cheetham
Dr Catharien Hilkens
et al.
Role of Aire in the Induction of Human Tolerogenic Dendritic Cells2014
Dr Desa Lilic
Severe Combined Immunodeficiency in Serbia and Montenegro Between Years 1986 and 2010: A Single-Center Experience2014
Dr Mario Abinun
Professor Andrew Cant
Dr Desa Lilic
Treatment Options for Severe Immunodeficiency Due to Gain-of-Function STAT-1 Mutation2014
Jie Zheng
Professor Drew Rowan
Dr Andrew Gennery
Dr Mario Abinun
Dr Desa Lilic
et al.
Gain-of-function STAT1 mutations alter STAT3 activation in patients with chronic mucocutaneous candidiasis2012
Dr Mario Abinun
Dr Andrew Gennery
Dr Desa Lilic
Mutation screening in STAT1, CARD9 and PKC-DELTA in patients with chronic mucocutaneous candidiasis2012
Dr Desa Lilic
Unravelling fungal immunity through primary immune deficiencies2012
1234